Cetera Trust Company N.A Buys Shares of 17,568 CVS Health Corporation $CVS

Cetera Trust Company N.A purchased a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 17,568 shares of the pharmacy operator’s stock, valued at approximately $1,817,000. CVS Health accounts for 0.9% of Cetera Trust Company N.A’s holdings, making the stock its 29th largest position.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Handelsbanken Fonder AB grew its stake in CVS Health by 83.6% during the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after purchasing an additional 496,124 shares in the last quarter. State Street Corp raised its position in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of CVS Health by 0.3% in the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock valued at $738,777,000 after buying an additional 31,249 shares during the period. Deutsche Bank AG boosted its stake in shares of CVS Health by 28.4% in the 4th quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after buying an additional 1,031,998 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of CVS Health during the second quarter worth about $49,622,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on CVS. Mizuho raised their target price on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Truist Financial increased their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Piper Sandler reaffirmed an “overweight” rating and set a $113.00 price objective on shares of CVS Health in a research report on Monday, June 1st. Finally, Cantor Fitzgerald boosted their target price on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Stock Up 1.1%

Shares of NYSE:CVS opened at $94.06 on Tuesday. The firm has a 50 day simple moving average of $101.88 and a 200-day simple moving average of $89.08. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $120.31 billion, a PE ratio of 24.88, a P/E/G ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period last year, the firm posted $1.81 EPS. The company’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.